Brain+’ CST-Assistant cited in leading Nordic Life Science magazine as an impactful health tech intervention for managing dementia
Copenhagen, Denmark, 30 April 2024 – Brain+ A/S (Nasdaq First North: BRAINP) ·Health tech, A.I. and Computer-Brain interfaces are making an impact on CNS disease treatments, beyond the traditional pharmaceutical treatments. (NLS magazine) ·The Brain+ CST-Assistant, which enables software-based delivery of Cognitive Stimulation Therapy for people with dementia, is highlighted as an impactful health tech treatment (NLS magazine) ·While CST itself is an effective and globally recognized dementia therapy, the future holds potential for combining it with